Fig. 3From: The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation Construction of immune genes risk model. a Multivariate analysis of the 12 immune genes that made up the risk model. b The risk index distribution of ccRCC patients in the training data set. c The survival status chart of ccRCC patients is based on the TCGA cohort. d The heatmap of 12 hub immune genes is based on the TCGA cohort. e Risk model survival curve analysis. f ROC curve to verify the ability of the risk model to predict prognosisBack to article page